22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
P/B ratio for 22nd Century Group, Inc. (XXII)
P/B ratio as of 2023: -0.46
According to 22nd Century Group, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.46. At the end of 2022 the company had a P/B ratio of 1.85.
P/B ratio history for 22nd Century Group, Inc. from 2006 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | -0.46 |
| 2022 | 1.85 |
| 2021 | 7.26 |
| 2020 | 6.92 |
| 2019 | 2.23 |
| 2018 | 4.34 |
| 2017 | 3.76 |
| 2016 | 3.46 |
| 2015 | 8.13 |
| 2014 | 6.50 |
| 2013 | 12.40 |
| 2012 | -3.72 |
| 2011 | -9.09 |
| 2010 | -129.24 |
| 2009 | -266.84 |
| 2008 | -771.17 |
| 2007 | 3596.58 |
| 2006 | -1818.72 |